Compare FTAIM & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares
Current Price
Current Price
| Metric | FTAIM | KRMD |
|---|---|---|
| Founded | N/A | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Corporate Leasing Services | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 192.5M |
| IPO Year | 2014 | 2019 |
| Metric | FTAIM | KRMD |
|---|---|---|
| Price | $27.25 | $3.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | 1.7K | ★ 221.0K |
| Earning Date | N/A | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1537.50 | 53.85 |
| EPS | ★ 2.42 | N/A |
| Revenue | ★ $2,507,409,000.00 | $41,127,366.00 |
| Revenue This Year | N/A | $20.32 |
| Revenue Next Year | N/A | $17.37 |
| P/E Ratio | $11.22 | ★ N/A |
| Revenue Growth | ★ 44.53 | 22.23 |
| 52 Week Low | $26.31 | $3.12 |
| 52 Week High | $27.81 | $6.61 |
| Indicator | FTAIM | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 43.06 | 29.99 |
| Support Level | $26.56 | N/A |
| Resistance Level | $27.43 | $3.43 |
| Average True Range (ATR) | 0.09 | 0.10 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 37.61 | 11.11 |
FTAI Aviation Ltd is an independent engine maintenance platform focused on the CFM56-5B, CFM56-7B, and V2500 aircraft engines, which power the 737NG and A320ceo aircraft. The company repairs and rebuilds engines in its maintenance facilities and with joint venture partners, and sells or leases engines through its proprietary Maintenance, Repair and Exchange (MRE) model under the Aerospace Products segment, which earns maximum revenue from North America and develops, repairs/refurbishes, and sells aircraft engines and aftermarket components. It also operates an Aviation Leasing segment, owning and managing a portfolio of on- and off-lease aircraft and engines, including engine transfers for rebuilding and sales.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.